ArticlePloS one2026
Adaptive and migration-enhanced tree seed algorithm for multi-threshold CT image segmentation and lung cancer recognition.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Tree-Seed Algorithm (TSA) is a swarm intelligence algorithm inspired by the propagation relationship between trees and seeds. However, the original TSA is prone to premature convergence and becomes trapped in local optima when addressing high-dimensional, complex optimization problems, limiting its practical efficacy. To overcome these limitations, this paper proposes an Adaptive and Migration-enhanced Tree Seed Algorithm (AMTSA), which integrates three key mechanisms to significantly enhance performance in solving complex optimization tasks. First, to effectively evade local optima, an adaptive tree migration mechanism is designed to dynamically adjust the search step-size and direction based on individual fitness, thereby improving global exploration. Second, to enhance the algorithm's adaptability and efficiency across different search stages, an adaptive seed generation strategy based on the dynamic Weibull distribution is introduced. This strategy enables flexible control over the number of seeds and promotes a balanced search throughout the solution space. Third, to mitigate convergence oscillations during the global search, a nonlinear step-size adjustment function inspired by the GBO algorithm is incorporated, which effectively improves convergence stability by responding to the iteration progress. Rigorous testing on the IEEE CEC 2014 benchmark functions demonstrates that AMTSA's overall performance surpasses not only state-of-the-art optimizers like JADE and LSHADE but also recent TSA variants, including STSA, fb-TSA, and MTSA. To further validate its robustness in high-dimensional spaces, AMTSA was tested on 30 benchmark functions at 30, 50, and 100 dimensions. Results show that AMTSA ranked first in the number of functions optimized best and exhibited the fastest convergence speed among all compared algorithms. In a real-world application, AMTSA was employed to optimize multi-threshold segmentation for lung cancer CT images. The resulting AMTSA-SVM classification model achieved an accuracy of 89.5%, significantly outperforming models such as standard SVM (76.22%), DE-SVM (82%), GA-SVM (79.33%), TSA-SVM (84.44%), and JADE-SVM (89.12%). In conclusion, the proposed AMTSA, by integrating adaptive migration, dynamic seed generation, and nonlinear step-size control, successfully addresses the inherent deficiencies of the native TSA, offering a more efficient and robust tool for solving high-dimensional, complex optimization problems. The AMTSA source code will be available at www.jianhuajiang.com.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.